Minnesota Medical Technologies

Minnesota Medical Technologies

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Minnesota Medical Technologies is a specialized medical device company targeting the underserved and stigmatized condition of fecal incontinence (FI). The company's core innovation is the StaySure™ device, developed in collaboration with leading gastroenterologists, which represents a preventative approach to managing FI. With a seasoned leadership team boasting deep experience in the continence care sector and medical device manufacturing, the company is positioned to commercialize its solution. Its mission is to restore dignity and control to patients through elegant, high-performance products that address significant unmet needs in global continence care.

Fecal IncontinenceContinence Care

Technology Platform

Expertise in medical-grade silicone technology and engineering for intimate medical devices, with in-house design of specialized production systems. Focus on creating preventative, non-absorbent mechanical solutions for continence.

Opportunities

A large and growing prevalent population suffering from fecal incontinence, which is under-discussed and underserved by current containment-based products.
A preventative device like StaySure™ addresses a clear unmet need and can command a premium in a multi-billion dollar global market for incontinence care.

Risk Factors

Commercial success depends entirely on market adoption of a single product in a stigma-laden category, requiring significant patient education and potentially challenging reimbursement.
The company faces execution risks in scaling manufacturing and competition from larger, established medtech firms.

Competitive Landscape

Competes within the broad incontinence care market, which is dominated by large consumer health companies selling absorbent pads and briefs (e.g., Kimberly-Clark, Procter & Gamble). Also faces potential competition from other medical device companies developing implantable or insertable technologies for FI, though StaySure's specific preventative mechanism may differentiate it from both low-tech absorbents and more invasive surgical options.